<?xml version="1.0" encoding="UTF-8"?>
<NDC>
<NDCCode>
70304-002-01
</NDCCode>
<PackageDescription>
1 mg in 1 BOTTLE, SPRAY (70304-002-01)
</PackageDescription>
<NDC11Code>
70304-0002-01
</NDC11Code>
<ProductNDC>
70304-002
</ProductNDC>
<ProductTypeName>
HUMAN PRESCRIPTION DRUG
</ProductTypeName>
<ProprietaryName>
Epinephrine Hypospray(r)
</ProprietaryName>
<ProprietaryNameSuffix/>
<NonProprietaryName>
Epinephrine Bitartrate
</NonProprietaryName>
<DosageFormName>
AEROSOL, SPRAY
</DosageFormName>
<RouteName>
TRANSDERMAL
</RouteName>
<StartMarketingDate>
20161010
</StartMarketingDate>
<EndMarketingDate/>
<MarketingCategoryName>
IND
</MarketingCategoryName>
<ApplicationNumber>
IND132473
</ApplicationNumber>
<LabelerName>
Langford Research Institute
</LabelerName>
<SubstanceName>
EPINEPHRINE
</SubstanceName>
<StrengthNumber>
1
</StrengthNumber>
<StrengthUnit>
mg/mg
</StrengthUnit>
<Pharm_Classes>
Adrenergic alpha-Agonists [MoA],Adrenergic beta-Agonists [MoA],alpha-Adrenergic Agonist [EPC],beta-Adrenergic Agonist [EPC],Catecholamine [EPC],Catecholamines [Chemical/Ingredient]
</Pharm_Classes>
<DEASchedule/>
<Status>
Deprecated
</Status>
<LastUpdate>
2017-12-27
</LastUpdate>
<PackageNdcExcludeFlag/>
<ProductNdcExcludeFlag>
N
</ProductNdcExcludeFlag>
<ListingRecordCertifiedThrough>
20181231
</ListingRecordCertifiedThrough>
<StartMarketingDatePackage/>
<EndMarketingDatePackage/>
<SamplePackage/>
</NDC>